OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
Publish Date Publish Date | Title Title | Period End Date Period End Date | Status Status |
---|---|---|---|
01/07/2024 | Quarterly Report | 11/30/2023 | A |
01/02/2024 | Attorney Letter with Respect to Current Information | 08/31/2023 | A |
11/27/2023 | Annual Report - Annual Report, Financials & Attorney Letter | 08/31/2023 | A |
07/10/2023 | Quarterly Report - Amended Quarterly Report v2 | 05/31/2023 | A |
06/18/2023 | Quarterly Report | 05/31/2023 | A |
04/09/2023 | Quarterly Report | 02/28/2023 | A |
01/25/2023 | Quarterly Report - Financial Statements - Amended | 11/30/2022 | A |
01/12/2023 | Quarterly Report - OTC Disclosure Statement | 11/30/2022 | A |
01/12/2023 | Quarterly Report - Financial Statements (Unaudited) | 11/30/2022 | A |
12/14/2022 | Attorney Letter with Respect to Current Information - Attorney Letter - Covering YE August 31, 2022 | 08/31/2022 | A |
Form Type Form Type | Received Received | Period End Date Period End Date | Report Report |
---|---|---|---|
15-15D | 06/26/2014 | ||
10-K | 02/11/2013 | 08/31/2012 | |
10-Q/A | 07/24/2012 | 05/31/2012 | |
10-Q | 07/23/2012 | 05/31/2012 | |
NT 10-Q | 07/16/2012 | 05/31/2012 | |
10-Q/A | 05/01/2012 | 02/29/2012 | |
10-Q | 04/23/2012 | 02/29/2012 | |
NT 10-Q | 04/17/2012 | 02/29/2012 | |
10-Q/A | 01/23/2012 | 11/30/2011 | |
10-Q | 01/17/2012 | 11/30/2011 |
No insider disclosure available for FLRE.
No SEC transactions available for FLRE.